Correction

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer (vol 5, 17499, 2015)

Journal

SCIENTIFIC REPORTS
Volume 13, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41598-023-30374-9

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available